AI
CELG

Atria Investments’s Celgene Corp CELG Stock Holding History

Atria Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,634
Closed -$1.25M – 1253
2019
Q3 		$1.25M Sell
12,634
-1,791
-12% -$170K 0.04% 354
2019
Q2 		$1.36M Sell
14,425
-1,914
-12% -$182K 0.05% 313
2019
Q1 		$1.54M Sell
16,339
-4,694
-22% -$411K 0.07% 253
2018
Q4 		$1.35M Sell
21,033
-2,486
-11% -$184K 0.06% 243
2018
Q3 		$2.1M Sell
23,519
-1,339
-5% -$118K 0.08% 216
2018
Q2 		$1.97M Sell
24,858
-10,243
-29% -$850K 0.09% 233
2018
Q1 		$3.13M Buy
35,101
+2,670
+8% +$256K 0.15% 131
2017
Q4 		$3.38M Buy
32,431
+6,179
+24% +$697K 0.17% 122
2017
Q3 		$3.83M Buy
26,252
+3,129
+14% +$426K 0.21% 88
2017
Q2 		$3M Buy
23,123
+3,787
+20% +$464K 0.18% 103
2017
Q1 		$2.41M Buy
19,336
+4,389
+29% +$525K 0.16% 142
2016
Q4 		$1.73M Buy
14,947
+715
+5% +$79.6K 0.13% 156
2016
Q3 		$1.49M Buy
14,232
+2,034
+17% +$220K 0.14% 140
2016
Q2 		$1.27M Sell
12,198
-531
-4% -$54.9K 0.14% 138
2016
Q1 		$1.27M Buy
12,729
+1,155
+10% +$119K 0.14% 110
2015
Q4 		$1.26M Buy
11,574
+1,453
+14% +$168K 0.14% 105
2015
Q3 		$1.09M Sell
10,121
-2,568
-20% -$319K 0.15% 98
2015
Q2 		$1.47M Buy
12,689
+1,544
+14% +$177K 0.17% 82
2015
Q1 		$1.28M Buy
11,145
+921
+9% +$110K 0.15% 101
2014
Q4 		$1.14M Sell
10,224
-209
-2% -$22K 0.12% 136
2014
Q3 		$989K Buy
10,433
+1,392
+15% +$126K 0.1% 172
2014
Q2 		$776K Buy
9,041
+513
+6% +$39K 0.08% 212
2014
Q1 		$595K Sell
8,528
-1,362
-14% -$108K 0.06% 258
2013
Q4 		$836K Buy
9,890
+2,102
+27% +$166K 0.08% 207
2013
Q3 		$600K Sell
7,788
-2,268
-23% -$159K 0.06% 244
2013
Q2 		$588K Buy
+10,056
New +$605K 0.07% 163

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Atria Investments's CELG Position: Q4 2019 in Review

Atria Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,634 shares — an estimated $1.25M sold.

Atria Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.83M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Atria Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Atria Investments sold 12,634 Celgene Corp shares in Q4 2019, an estimated $1.25M.
  • Atria Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Atria Investments's Celgene Corp position peaked at $3.83M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Atria Investments's 13F filing for Q4 2019, filed 11 Feb 2020.